Group One Trading, L.P. Mereo Biopharma Group PLC Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.71 - $1.22 $26,230 - $45,071	-36,944 Reduced 81.96%	8,130 $5,000
Q4 2022 Feb 09, 2023	SELL	$0.5 - $1.01 $8,407 - $16,982	-16,814 Reduced 27.17%	45,074 $33,000
Q3 2022 Nov 09, 2022	BUY	$0.82 - $1.73 $11,141 - $23,505	13,587 Added 28.13%	61,888 $53,000
Q2 2022 Aug 11, 2022	BUY	$0.33 - $1.69 $9,770 - $50,035	29,607 Added 158.38%	48,301 $54,000
Q1 2022 May 12, 2022	BUY	$1.04 - $1.7 $416 - $680	400 Added 2.19%	18,694 $21,000
Q4 2021 Feb 11, 2022	BUY	$1.51 - $2.59 $21,846 - $37,472	14,468 Added 378.15%	18,294 $29,000
Q3 2021 Nov 12, 2021	SELL	$2.2 - $3.17 $16,720 - $24,092	-7,600 Reduced 66.51%	3,826 $9,000
Q2 2021 Aug 10, 2021	BUY	$2.94 - $4.08 $33,592 - $46,618	11,426 New	11,426 $36,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $376M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.